• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    2.44 Up 0.09(3.83%) Dec 19, 4:00PM EST
    |After Hours : 2.44 Up 0.00 (0.18%) Dec 19, 5:35PM EST
    Add to Portfolio
    Prev Close:2.35
    Open:2.33
    Bid:N/A
    Ask:2.70 x 500
    1y Target Est:6.50
    Beta:1.95
    Next Earnings Date:N/A
    Day's Range:2.30 - 2.57
    52wk Range:1.56 - 5.00
    Volume:3,770,240
    Avg Vol (3m):569,336
    Market Cap:214.21M
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    RIGLUp 3.83%214.21M
    AMGNUp 1.00%129.44B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.88
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.04
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback